April 7, 2022 Acad, Gov/Utilities Product Launch

Xylem’s New Smart Wastewater Treatment Solution Cuts Operating Costs and Reduces Energy Use by 25%

Breakthrough Digital Innovation Provides Wastewater Operators Real-Time Process Recommendations to Optimize Chemical Usage and Aeration STOCKHOLM–(BUSINESS WIRE)–Apr. 7, 2022– Wastewater utilities can now achieve compliance targets while cutting energy consumption from aeration by up to 25% with Xylem Edge Control. This off-the-shelf suite of digital solutions for conventional activated sludge (CAS) plants marks the latest... Read more

March 31, 2022 Atomic Spectroscopy Product Launch

HiFi Reads Enable Telomere-to-Telomere Consortium to Fill the Final Gaps in the Human Genome, Heralding a New Era of Research into Genetic Diseases and Human Biology

MENLO PARK, Calif., March 31, 2022 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing solutions, announced today PacBio’s essential contribution to the completion of the first truly complete human reference genome. The Telomere-to-Telomere (T2T) Consortium, an international team of scientists from the US National Human Genome Research Institute and... Read more

March 31, 2022 Clinical Research/Diagn. Microscopy Product Launch

GE Healthcare and Leading Korean Hospital Aim to Accelerate AI Ecosystem Using GE’s New Edison Digital Health Platform

Seoul National University Bundang Hospital to leverage GE Healthcare’s artificial intelligence (AI) capabilities to take the lead in using medical AI in their hospital system. The two collaborators intend to support and accelerate Korean start-ups to test and develop clinical applications on Edison Digital Health Platform Seoul, South Korea – March 31, 2022 — GE... Read more

March 23, 2022 Bio/Pharma/CRO Clinical Research/Diagn. Product Launch

GE Healthcare announces first patient dosed in phase III clinical trial for new dopamine transporter imaging radiopharmaceutical

First patient dosed in Phase III clinical trial for PET radiopharmaceutical Next stage clinical study also proceeding for SPECT radiopharmaceutical Both imaging agents aim to assist in the evaluation of adult patients with suspected Parkinsonian syndromes, support research and improve patient care Builds on market leadership with SPECT agent DaTscan™ (Ioflupane I 123 Injection), to... Read more

March 15, 2022 Lab Top-10 PAI Top-10 Product Launch

Bruker Leads $46 Million New Financing Round for PrognomiQ to Advance Development of Next-Generation Multi-omics Liquid Biopsy Products for Cancer

San Mateo, Calif. – March 15, 2022 – PrognomiQ – a healthcare company focused on harnessing the power of multi-omics data to transform the detection and early treatment selection and monitoring of cancer and other complex diseases – today announced it has raised $46 million in financing led by Bruker Corporation, with participation from new... Read more